Yu-Hui Wang

1.6k total citations
32 papers, 1.1k citations indexed

About

Yu-Hui Wang is a scholar working on Oncology, Management of Technology and Innovation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu-Hui Wang has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Management of Technology and Innovation and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu-Hui Wang's work include Intellectual Property and Patents (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Yu-Hui Wang is often cited by papers focused on Intellectual Property and Patents (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Yu-Hui Wang collaborates with scholars based in Taiwan, United States and China. Yu-Hui Wang's co-authors include Amy J.C. Trappey, Ching‐Hung Lee, Chien‐Feng Li, Hsuan-Ying Huang, Shau-Hsuan Li, Yow-Ling Shiue, Shih-Chen Yu, Fu-Min Fang, Wen-Ren Wu and Li‐Tzong Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Cell Biology and Clinical Cancer Research.

In The Last Decade

Yu-Hui Wang

31 papers receiving 1.1k citations

Peers

Countries citing papers authored by Yu-Hui Wang

Since Specialization

Citations

This map shows the geographic impact of Yu-Hui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Hui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Hui Wang more than expected).

Fields of papers citing papers by Yu-Hui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Hui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Hui Wang. The network helps show where Yu-Hui Wang may publish in the future.

Co-authorship network of co-authors of Yu-Hui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Hui Wang. A scholar is included among the top collaborators of Yu-Hui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Hui Wang. Yu-Hui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring Technology-Driven Technology Roadmaps (TRM) for Wearable Biosensors in Healthcare 2024 ·IRBM ·Yu-Hui Wang	1
2	Author Correction: SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis 2021 ·Nature Cell Biology ·Guihua Wang, Jie Long, Yuan Gao, Weina Zhang, Fei Han, Chuan Xu, Li Sun, (unknown), Jingqin Lan, Zhenlin Hou, Zhen Cai, Guoxiang Jin, (unknown), Yu-Hui Wang, Junbo Hu, Tsai‐Yu Chen, Hongyu Li, Min Gyu Lee, Hui‐Kuan Lin	4
3	Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer 2019 ·Clinical Cancer Research ·Ruoshi Shi, Nikolina Radulovich, Christine Ng, Ni Liu, Hirotsugu Notsuda, Michael Cabanero, Sebastião N. Martins-Filho, Vibha Raghavan, Quan Li, Arvind Singh Mer, (unknown), Ming Li, Yu-Hui Wang, Laura Tamblyn, Nhu‐An Pham, Benjamin Haibe‐Kains, Geoffrey Liu, Nadeem Moghal, Ming‐Sound Tsao	204
4	SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis 2019 ·Nature Cell Biology ·Guihua Wang, Jie Long, Yuan Gao, Weina Zhang, Fei Han, Chuan Xu, Li Sun, (unknown), Jingqin Lan, Zhenlin Hou, Zhen Cai, Guoxiang Jin, (unknown), Yu-Hui Wang, Junbo Hu, Tsai‐Yu Chen, Hongyu Li, Min Gyu Lee, Hui‐Kuan Lin	143
5	Explore technology innovation and intelligence for IoT (Internet of Things) based eyewear technology 2017 ·Technological Forecasting and Social Change ·Yu-Hui Wang, (unknown)	32
6	Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder 2016 ·Clinical Cancer Research ·Wei‐Jan Wang, Chien‐Feng Li, Yu‐Yi Chu, Yu-Hui Wang, (unknown), Chia-Jui Yen, Wen-Chang Chang, Ju-Ming Wang	51
7	Modularized design-oriented systematic inventive thinking approach supporting collaborative service innovations 2016 ·Advanced Engineering Informatics ·Yu-Hui Wang, Ching‐Hung Lee, Amy J.C. Trappey	35
8	Applying Patent-Based Fuzzy Quality Function Deployment to Explore Prospective VoLTE Technologies 2016 ·International Journal of Fuzzy Systems ·Yu-Hui Wang, (unknown)	7
9	Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance 2014 ·Oncotarget ·Chien‐Feng Li, Fu-Min Fang, Hsing-Jien Kung, Li‐Tzong Chen, Junwen Wang, Jen-Wei Tsai, (unknown), Yu-Hui Wang, Shau-Hsuan Li, Hsuan-Ying Huang	19
10	AMACR Amplification in Myxofibrosarcomas: A Mechanism of Overexpression That Promotes Cell Proliferation with Therapeutic Relevance 2014 ·Clinical Cancer Research ·Chien‐Feng Li, Fu-Min Fang, Jui Lan, Junwen Wang, Hsing-Jien Kung, Li‐Tzong Chen, (unknown), Shau-Hsuan Li, Yu-Hui Wang, (unknown), Shih-Chen Yu, Hsuan-Ying Huang	34
11	ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance 2013 ·Clinical Cancer Research ·Hsuan-Ying Huang, Wen-Ren Wu, Yu-Hui Wang, Junwen Wang, Fu-Min Fang, Jen-Wei Tsai, Shau-Hsuan Li, (unknown), Shih-Chen Yu, Jui Lan, Yow-Ling Shiue, (unknown), Li‐Tzong Chen, Chien‐Feng Li	118
12	Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma 2013 ·Chien‐Feng Li, Li‐Tzong Chen, Ching-Yih Lin, Yu-Hui Wang, Hsuan-Ying Huang, Chung‐Hsi Hsing, Chia‐Jung Tsai, Yow-Ling Shiue	2
13	Ontology-based Patent Licensing and Litigation Strategic Knowledge System for the Light Emitting Diode Industry 2013 ·SHILAP Revista de lepidopterología ·Amy J.C. Trappey, Yu-Hui Wang, Charles V. Trappey, Chunyi Wu, Dong Lin	2
14	Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation 2012 ·Journal of Clinical Pathology ·Ching-Yih Lin, Yu-Feng Tian, Li-Ching Wu, Li‐Tzong Chen, Li-Ching Lin, Chung‐Hsi Hsing, Sung-Wei Lee, Ming-Jen Sheu, Hao-Hsien Lee, Yu-Hui Wang, Yow-Ling Shiue, Wen-Ren Wu, Hsuan-Ying Huang, (unknown), Chien‐Feng Li, Shang‐Hung Chen	22
15	Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator 2012 ·Journal of Clinical Pathology ·Li-Ching Wu, Li‐Tzong Chen, (unknown), Chun‐Mao Lin, Ching-Yih Lin, (unknown), (unknown), Yih‐Huei Uen, Yow-Ling Shiue, Yu-Hui Wang, (unknown), Wen-Ren Wu, Shau-Hsuan Li, Masaya Iwamuro, (unknown), Hsuan-Ying Huang, Chien‐Feng Li	15
16	Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics 2012 ·Clinical Cancer Research ·Chien‐Feng Li, Ju-Ming Wang, Hong‐Yo Kang, Chiung-Kuei Huang, Junwen Wang, Fu-Min Fang, Yu-Hui Wang, Wen-Ren Wu, Shau-Hsuan Li, Shih-Chen Yu, Jen‐Chieh Lee, Jui Lan, Yow-Ling Shiue, Li-Ching Wu, Hsuan-Ying Huang	39
17	Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator 2012 ·Annals of Surgical Oncology ·Jen-Wei Tsai, Chien‐Feng Li, Yu‐Chien Kao, Junwen Wang, Fu-Min Fang, Yu-Hui Wang, Wen-Ren Wu, Li-Ching Wu, Chung‐Hsi Hsing, Shau-Hsuan Li, Shih-Chen Yu, Jui Lan, Hsuan-Ying Huang	21
18	EGFR Nuclear Import in Gallbladder Carcinoma: Nuclear Phosphorylated EGFR Upregulates iNOS Expression and Confers Independent Prognostic Impact 2011 ·Annals of Surgical Oncology ·Chien‐Feng Li, (unknown), Ju-Ming Wang, Ching‐Cherng Tzeng, (unknown), (unknown), Shau-Hsuan Li, (unknown), Yu-Hui Wang, Shih-Chen Yu, Yow-Ling Shiue, (unknown), Wen-Ling Wang, Li‐Tzong Chen, Hsuan-Ying Huang	23
19	Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors 2009 ·Clinical Cancer Research ·Hsuan-Ying Huang, Shau-Hsuan Li, Shih-Chen Yu, Fong‐Fu Chou, Ching‐Cherng Tzeng, Tsung‐Hui Hu, Yih‐Huei Uen, (unknown), Yu-Hui Wang, Fu-Min Fang, (unknown), (unknown), (unknown), Chien‐Feng Li	41
20	A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients 2009 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Lei Zhao, Xunde Xian, (unknown), Wei Huang, Yu-Hui Wang, Odilo Mueller, Elaine Chang, Yves Konigshofer, (unknown), Chaojie Liu, Jin‐Kui Yang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact